Your browser doesn't support javascript.
loading
Editorial: Resistance to Endocrine Therapies in Cancer.
Ranganathan, Prathibha; Chakrabarty, Anindita; Hiscox, Stephen; Limaye, Anil Mukund; Vella, Veronica.
Affiliation
  • Ranganathan P; Centre for Human Genetics, Bengaluru, India.
  • Chakrabarty A; Department of Life Sciences, Shiv Nadar University, Greater Noida, India.
  • Hiscox S; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
  • Limaye AM; Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, India.
  • Vella V; Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Hospital, Catania, Italy.
Front Endocrinol (Lausanne) ; 11: 196, 2020.
Article in En | MEDLINE | ID: mdl-32328035
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2020 Document type: Article Affiliation country: India Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2020 Document type: Article Affiliation country: India Country of publication: Switzerland